claim: the approved dose of ivermectin alone is still the ideal dose for the treatment of covid-19
evidence_1: in summary, the likelihood of a successful clinical trial using the approved dose of ivermectin is low.", "repurposing drugs for use in coronavirus disease 2019 (covid-19) treatment is an ideal strategy but is only feasible when product safety has been established and experiments of repurposed drugs are conducted at clinically relevant concentrations.")